Oxaliplatin and 5-FU Based Preoperative Chemoradiation
Effect of treatment, safety profile and quality of life scorings.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Georg Høyer, DH
South region committee for research ethics in Norway
Norway: Norwegian Medicines Agency